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Abstract
Background: Bone morphogenetic protein7 (BMP7) and bone morphogenetic protein 8b (BMP8b) can induce browning of white
adipose tissue.
Objectives: The present study aimed to investigate the antioxidative effects of hydro-alcoholic extract of Nigella sativa on the repair
of oxidative damage caused by a high-fat diet. Also, Bmp7 and Bmp8b gene expressions were investigated on white adipose tissue of
the rats and then compared with metformin effects.
Methods: Eighty rats were divided into two groups of prevention and treatment; then each set was divided into four sub-groups
based on the administered diet (i.e., ordinary, fat, metformin, and extract of Nigella sativa). Lipid profile, paraoxonase1, malondi-
aldehyde (MDA), HDL, and antioxidant capacity were measured in serum samples, and relative Bmp7 and Bmp8b gene expressions
were calculated in white adipose tissue.
Results: For both prevention and treatment sets, the weight of rats who received a high-fat diet decreased more compared to those
in the normal diet group. The weight of rats who received metformin or nigella extract was also decreased compared to the high-fat
diet group. MDA was also increased, but total antioxidant capacity and catalase were decreased in rats of the high-fat diet group
compared to the normal diet group. MDA was also declined in nigella receiving rats, but liver PON1 activity, total antioxidant ca-
pacity, and catalase were increased, compared to the second group (P < 0.05). In the prevention and treatment set, Bmp8b gene
expression was increased in the metformin and Nigella sativa groups, whereas it was decreased among those who received a high-
fat diet. Bmp7 gene expression was decreased in the high-fat diet set, but metformin and Nigella sativa extract didn’t influence Bmp7
gene expression.
Conclusions: This study demonstrated that Nigella sativa extract has a protective role against oxidative stress in a high-fat diet.
Keywords: Nigella sativa, Obesity, BMP7, BMP8b
1. Background
Obesity is associated with excessive accumulation of
tissue fat and is considered one of the world’s largest
health problems, particularly in industrialized countries
(1). Besides, it’s the most important growing risk factor of
cardiovascular diseases, diabetes, and cancer among non-
smokers (2, 3). Brown adipose tissue containing multiple
cells has a mitochondrial abundance and expresses high
levels of uncoupling protein 1 (ucp1) (4). Bone morpho-
genetic protein7 (BMP7) is a major factor for the differentia-
tion of primary cells into brown adipose tissue (5, 6). Bone
morphogenetic protein 8b (BMP8b) belongs to the trans-
forming growth factor-beta (TGF beta) superfamily. BMP8b
has multiple roles and, like BMP7, can stimulate the tran-
sition of white adipose tissue to brown adipose tissue (7).
Obese people usually have higher levels of oxidative stress
(OS) biomarkers, such as malondialdehyde (MDA) gener-
ated from the peroxidation of polyunsaturated fatty acids
(8). As obesity persists, natural sources of antioxidants in
the body begin to decline, which in turn causes more de-
cline in the activity of anti-oxidative enzymes.
There are studies that mentioned to anti-obesity prop-
erties of herbal drugs such as Nigella sativa (9). Nigella
sativa, black sowing, is an annual flowering plant, native
to different regions of Southern Europe and some parts of
Asia, which is widely using in the food and pharmaceutical
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industries. The main constituent of Nigella sativa seeds is
thymoquinone (TQ) that holds properties to increases the
activity of catalase, superoxide dismutase (SOD), and glu-
tathione peroxidase (10). In this study, we examined the ef-
fects of Nigella sativa extract on the expression of Bmp7 and
Bmp8b genes.
2. Objectives
The results of the present study help to elucidate the
process in which these genes cause weight loss after ad-
ministration of Nigella sativa, which in turn offers new
strategies to control the weight. Furthermore, its findings
are useful for reducing obesity-related diseases in the com-
munity.
3. Methods
3.1. Preparing the Plant Extract
Nigella sativa seeds were purchased from a grocery in
Shahrekord, Iran, and authenticated in the Medical Plants
Research Center of Shahrekord University of Medical Sci-
ences, Iran.
The hydro-alcoholic extract of Nigella sativa was pre-
pared by maceration method. Initially, 300 g of the Nigella
sativa was chopped in a suitable container, and 500 mL
ethanol 70% was added and left at room temperature for
one week. Then, it was filtered, and the solvent was evap-
orated using a rotary evaporator. Finally, it was concen-
trated at 37°C in the oven and kept in a fridge until use.
In this study, eighty-eight-week old male Wistar rats
(180 ± 20 grams) were selected. Animals were housed in
the standard and similar conditions (temperature 22°C ±
2, 12 hours of light and 12 hours of dark cycle) for one
week. Afterward, the rats were fed with a chow diet and
water. The study protocol was approved by the Ethics Com-
mittee of the Shahrekord Medical University (ethical code:
IR.SKUMS.REC. 93.8.2, 22/11/2014). The Nigella sativa extract
was prepared in standard practice under the supervision
of a phytochemistry expert. Metformin was purchased
from Sigma, USA, and dissolved in distilled water.
After one week, rats were divided into two sets, each
with 40 subjects, as follows: set A (obesity prevention),
treated for 45 days; and set B (obesity treatment); then,
based on their weight, the rats were into 4 groups. Nor-
mal control groups had oral gavage with a volume of dis-
tilled water, equivalent with other groups. The second,
third, and fourth groups were fed with a high-fat diet con-
taining 57.5% animal chow, 15% saturated animal fat, 5%
oil plant, 20 % sucrose, and 2.5% cholesterol (11). As oral
gavage may cause shock in rats, to reduce the rats’ stress
level, 1 mL distilled water once per day was administered
along with oral gavage in the high-fat control group. The
third group, along with a high-fat diet, received metformin
300 mg/kg/day by oral gavage (12). The fourth group, along
with a high-fat diet received 200 mg/kg/day Nigella sativa
extract (40 mg dried powder of extract which was dis-
solved in 1 mL distilled water) via oral gavage (13).
3.2. In Set B
The first group, the normal control group, was fed with
a normal diet for 45 days, then for the above-mentioned
reasons, along with a normal diet, they received 1 mL dis-
tilled water per day for 35 days. The second, third, and
fourth groups at first received a high-fat diet for 45 days;
Then, rats in the second group, for the above-mentioned
reason, along with a normal diet, received 1 mL distilled wa-
ter per day by oral gavage for 32 days. The third group, for
32 days, along with a normal diet, received metformin 300
mg/kg/day, and the fourth group, for 32 days along with
normal diet, received Nigella sativa extract 200 mg/kg/day
by oral gavage.
Rats were weighted every week at room temperature
(25°C) with a digital scale (PAND, PX3000). At the end of
each phase, animals were anesthetized using chloroform
and blood samples were taken immediately from their
heart. Then, samples were transferred into capped tubes
with no anticoagulant, and the serum was separated by
centrifugation. Glucose, cholesterol, triglycerides, alanine
transaminase (ALT), aspartate transaminase (AST), and ALP
were measured by an auto-analyzer (BT3000, Italy) using a
commercial kit (Pars Azmon, Iran).
Serum MDA concentration was measured using HPLC
(Agilent, USA) based on the Agarwal method (14). The MDA
was separated on the C18 column at a flow rate of 1 mL/min
and then detected using a fluorescence detector (excita-
tion: 525 nm; emission: 560 nm). Total antioxidant capac-
ity of serum was measured by the FRAP assay using 2, 4, and
6-tripyridyl s triazine (TPTZ) (Sigma Aldrich).
To evaluate the liver catalase activity, the liver tissue
homogenate was prepared in normal saline. Briefly, the
liver tissue homogenate was prepared in ice-cold normal
saline (1:10 w/v, tissue/saline) through an automatic ho-
mogenate machine and then centrifuged at 2800 g for 15
min at 4°C to obtain the homogenate supernatant for the
assay of the liver catalase activity. The catalase activity was
measured using the Aebi method (15). Aryl esterase activity
of serum paraoxonase1 was measured spectrophotometri-
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cally in the kinetic mode using phenylacetate (Sigma, USA)
(16, 17).
To extract RNA, a small piece of abdominal white adi-
pose tissue was isolated from each rat and transferred into
a microtube. RNA was extracted from white adipose tis-
sue by trizol (Trizol Reagent- BIOFLUX Kit), and its quality
and quantity were estimated using a nanodrop (thermo
scientific nanodrop 2000 spectrophotometer, USA). The ra-
tios of absorbance at 260 nm and 280 nm were used to as-
sess the purity of RNA. Complementary DNA (cDNA) was
synthesized using a cDNA Synthesis kit (Thermo Fisher Sci-
entific Inc., Walthm, MA) according to the manufacturer’s
protocol. RT-qPCR was performed using Rotor-gene system
(Corbett Research, Sydney, Australia) and CYBR green kit
(Thermo Fisher Scientific Inc.) by real-time PCR. Each 20
µL reaction contained 10µL of SYBR Green PCR Master Mix,
1 µL of each forward and reverse primer (10 µM), 5 µL of
RNase-free water, and 3 µL of cDNA (about 50 ng). Primers
were designed using oligo 7 software. Amplified fragment
length and primer sequences for the desired gene are pro-
vided in Table 1.
The products were amplified according to the follow-
ing protocol: Initial enzyme activation at 95°C for 10 mins
followed by 40 cycles of 95°C for 15 seconds, 61°C for 20
seconds, and 72°C for 25 seconds. PCR product size was
144, 90, and 116 base-pairs for beta-actin, BMP7, and BMP8b
genes, respectively. The relative gene expression of the
Bmp7 and Bmp8b gene was measured and normalized us-
ing beta-actin as an independent internal control gene by
the comparative CT (∆∆CT) method.
3.3. Western Blot
To determine the BMP7 and BMP8b expression at the
protein level, abdominal white adipose tissue extracts
were used. Initially, about 30 mg white adipose tissue was
lysed in RIPA buffer (50 mM Tris-Cl, 0.1% sodium deoxy-
cholate, 150 mM NaCl, pH = 7.5). The lysate was centrifuged,
and the supernatant was separated, and the total protein
concentration was measured using the Bradford method.
Equal amounts of protein (30µg) per lane were loaded
into SDS-PAGE. The proteins were blotted using poly vinyli-
dene difluoride (PVDF) membranes (Roche-Germany) and
run at 120 V for 2 hours in transfer buffer (25 mM Tris,
192 mM glycine, 20% methanol). PVDF membranes were
blocked overnight at 4°C with 5% skim milk in tris-buffered
saline containing 0.1% Tween 20 (TBST).
After washing three times with TBST buffer, the blots
were incubated with antibodies against BMP7, BMP8b,
and anti-β-actin (Abcam-Cambridge, UK). Blotting mem-
brane was then washed, incubated for 90 mins with
HRP-conjugated secondary antibody using rabbit IgG
(Abcam-Cambridge, UK) and were visualized by 3,3,5,5-
tetramethylbenzidine (Roche Diagnostics, Germany). The
density of bands on a western blot was analyzed with Im-
age G software.
Western blot analysis was performed in triplicate.
3.4. Statistical Analysis
Statistical analyzes were performed using the non-
parametric Kruskal-Wallis test. Pair comparisons between
the groups were performed by the Mann-Whitney test.
All experiments were performed in triplicate. The results
are expressed as the mean and standard error of mean
(SEM). Statistical significance was considered when P value
< 0.05.
4. Results
4.1. The Prevention Set
The weight of rats was increased in the second group
(high-fat diet) compared to the control group (normal
diet). Glucose, cholesterol, and weight of rats were de-
creased in the fourth group (receiving the Nigella sativa ex-
tract) compared to the high-fat group (P < 0.05) (Table 2).
As shown in Table 2: glucose, cholesterol, TG, and high-
density lipoprotein (HDL) in the Nigella sativa group were
decreased compared to the high-fat diet group (P < 0.05).
Liver PON1 was increased in the Nigella sativa group com-
pared to the high-fat diet group.
MDA increased in the group who received metformin
compared to the high-fat diet group (P < 0.05). Total an-
tioxidant capacity (FRAP) was increased in rats that re-
ceived Nigella sativa compared to the high-fat diet group
(Table 2) (P < 0.05). Also, the amount of FRAP and cata-
lase was increased in the sera of treated rats in the Nigella
sativa extract group compared to the high-fat diet group (P
< 0.05).
4.2. The Treatment Group
After 5 weeks of treatment, rats’ weight in the high-
fat diet group was increased, while in the metformin and
Nigella sativa groups, it was decreased compared to the
high-fat diet group (P < 0.05). HDL and PON1 in the rats’
serum were decreased in the high-fat diet group compared
to the control group but were increased in theNigella sativa
extract group (P < 0.05) (Table 3). As shown in Table 3, the
MDA and AST were increased, and FRAP and catalase were
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Table 1. Primer Sequences Used in the Study










Table 2. Summary of Test Measurements in Preventive set in Different Groupsa , b
Group (N = 10)
Control Fat Metformin Nigella
PON1, IU/dL 499± 107.4 471± 89.8 488± 173.2 516± 106.6
HDL, mg/dL 53.8± 12.4 51.5± 7.3 48.3± 9.9 38.2± 6.8c
TG, mg/dL 126.6± 41.9 162.1± 41.2 151.5± 32.3 136.2± 37.2
TC, mg/dL 57.1± 12.7 52.3± 6.4 48.8± 6.5 38.3± 4.4c
GLc, mg/dL 206.8± 16.8 277.1± 78d 216± 47.3 203± 44.7c
Weight, g 284.1± 23.3 297.6± 29.8 271.1± 28.3 264.7c± 19
MDA, mmol/L 4.5± 1 5.6± 1 9.9± 6.7c 4.1± 1.6
CAT, IU/mg protein 47.7± 15.4 36.3± 11.4 37.5± 14.1 50.22c± 7.8
FRAP, µmol/L 1148.1± 156.8 910.3± 60.9 1093.6± 118.4c 1088.15± 189.9c
ALP, IU/dL 310.3± 90.8 636.7± 95.9d 577.1± 173.2 630± 114.9
ALT, IU/L 31± 69 48.5± 25.5 54.1± 12.8 43.2± 4.3
AST, IU/L 104.4± 21.7 140± 25.7 140.4± 13.6 108.3± 22. 5c
Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CAT, catalase; FRAP, serum antioxidant capacity; HDL, high density
lipoprotein; MDA, malondialdehyde; PON1, paraoxonase 1; TG, triglyceride; TC, total cholesterol.
aValues are expressed as mean± SD.
bTen male Wistar rats were in each group; control: normal diet, fat: high-fat diet only, metformin: the group receiving metformin 300 mg per kg body weight, Nigella:
the group receiving Nigella sativa extract 200 mg per kg body weight.
cP < 0.05 compared to the group high-fat diet group.
dP < 0.05 compared to the normal diet group.
decreased in the high-fat diet group compared to the nor-
mal diet group (P < 0.05).
MDA, ALP, and catalase activity were increased in the
metformin group compared to the high-fat diet group (P
< 0.05). MDA in the Nigella sativa extract group was de-
creased, but FRAP and catalase were increased compared
to the high-fat diet group. (P < 0.05).
4.3. Gene Expression
As shown in Figure 1A, in the prevention set, Bmp7 gene
expression was decreased by 2.23 times in the high-fat diet
compared to the normal diet group. Based on the findings,
the expression of the Bmp7 gene in metformin and Nigella
sativa groups didn’t change compared to the high-fat diet
group.
Also, as shown in Figure 1A, the expression of the
Bmp8b gene was decreased in the high-fat diet group com-
pared to the normal diet group (P < 0.05), which suggests
repression of gene expression in the high-fat diet group.
Also, as shown in Figure 1A, the expression of the Bmp8b
gene was increased by 7.5 times in rats that received met-
formin and by 11.87 times in rats that received the Nigella
sativa extract compared to the high-fat diet group (P <
0.05).
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Table 3. Summary of Test Measurements in Treatment Set in Different Groupsa , b
Group (N = 10)
Control Fat Metformin Nigella
PON1, IU/dL 622± 161.4 485± 116.9c 437± 175.6 638± 207.1d
HDL, mg/dL 49.6± 14.2 37.5± 5.5c 44.5± 9.6d 50.1± 7.7d
TG, mg/dL 88.8± 42.6 114.9± 33.3 84.1± 15.9d 98± 13.3
TC, mg/dL 53.3± 7.5 55.5± 5.9 56.5± 11.3 54.4± 11.8
GLc, mg/dL 191.6± 49.5 230.9± 36.6c 219.1± 42.1 243.1± 31.4
Weight, g 304.9± 50.4 323.2± 34.7 304.6± 46.9 286.3± 46.8d
MDA, mmol/L 2.9± 0.5 7.4± 2.8c 7.9± 2.9 3.2± 0.9
CAT, IU/mg protein 24.3± 5.2 13.8± 4.3 23.6± 4.9d 20.8± 6.3d
FRAP, µmol/L 974.9± 195.3 806.2± 109.8c 883.6± 134.5 1297.2± 279.7d
ALP, IU/dL 349.3± 136.9 421± 96.2 645.1± 188.9d 398.4± 124.4
ALT, IU/L 43.5± 21.7 48.6± 22.8 50.1± 12.7 40.6± 13.9
AST, IU/L 103.2± 55.3 198.1± 97.4c 180.3± 79.8 176.7± 52.5
Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CAT, catalase; FRAP, serum antioxidant capacity; HDL, high density
lipoprotein; MDA, malondialdehyde; PON1, paraoxonase 1; TG, triglyceride.
aValues are expressed as mean± SD.
bTen male Wistar rats were in each group; control: normal diet, fat: high-fat diet only, metformin: the group receiving metformin 300 mg per kg body weight, Nigella:
the group receiving Nigella sativa extract 200 mg per kg body weight).
cP < 0.05 compared to the normal diet group.
dP < 0.05 compared to the group high-fat diet group.
Western blot analysis confirmed the changes observed
at BMP7 and BMP8b protein levels (Figure 1B) in the preven-
tion set. In western blot analysis, beta-actin (42 kDa) was
used as an internal control.
In the treatment set, as shown in Figure 2A, the ex-
pression of the Bmp7 gene was decreased by 1.46 times
in the high-fat diet group compared to the normal diet
group. While the Bmp7 gene expression was increased
by 1.46 times in the metformin-treated group and by 1.35
times in the group that received the Nigella sativa extract
compared to the high-fat diet group.
As shown in Figure 2A, the Bmp8b gene expression in
the high-fat diet group was decreased significantly com-
pared to the normal diet group, but in the metformin and
Nigella sativa extract group, the expression of the Bmp8b
gene was increased again compared to the group received
a high-fat diet (P < 0.05).
As shown in Figure 2B, western blot analysis confirmed
the changes observed at BMP7 and BMP8b protein levels in
the treatment set.
5. Discussion
In the prevention set, ALT, MDA, and ALP were increased
in the high-fat diet group compared to the normal diet
group, which suggests liver malfunctioning in the high-fat
diet group. High MDA is likely due to the decreased level
of anti-oxidative enzymes. Catalase activity and FRAP were
decreased in the high-fat diet group, which indicates the
oxidative stress and active radicals generated by the high-
fat diet. We can argue that oxidative stress has suppressed
the serum antioxidant capacity, which in turn caused in-
creased levels of oxidized lipid and MDA.
A study reported that administration of Nigella sativa
was associated with decreased levels of MDA, as an is-
chemic marker (18). According to the previous studies,
treating rats with Nigella sativa is associated with de-
creased total cholesterol, LDL-C, and TG and increased lev-
els of total antioxidant capacity, catalase, superoxide dis-
mutase, and HDL (19-21).
In this study, administration of Nigella sativaextract for
45 days in the prevention set was associated with a small
reduction in TG, whereas the reduction in total cholesterol
and the increase in total antioxidant capacity (FRAP) were
very significant compared to untreated control groups. Be-
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Figure 1. Gene expression and western blot in prevention set
sides, administration of extract caused a reduction in HDL-
C, but it worth noting that the ratio of HDL-C to total choles-
terol in the extract receiving group was higher than the
high-fat diet group, which suggests the positive effect of
the extract on lipoproteins level.
Ghatak et al. (22) reported that metformin could im-
prove lipid profile and reduced oxidative stress, as well. In
the present study, AST and serum MDA were increased af-
ter administration of metformin. Apparently, metformin
could not reduce oxidative stress in the high-fat diet. As
a result, the MDA level in the metformin group was in-
creased compared to the high-fat diet group. Based on
the findings, administering the hydro-alcoholic extract of
Nigella sativa for 32 days resulted in decreased levels of
TG and MDA and increased HDL, catalase, and FRAP. In-
creased antioxidant capacity and catalase activity in the
Nigella sativaextract group can be attributed to polyphenol
as an antioxidant compound and/or due to thymoquinone,
which may increase the antioxidant capacity of cells.
Weight gain in the high-fat diet group, compared to
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Figure 2. Gene expression and western blot in treatment set
the control group, indicates the effectiveness of the high-
fat diet regimen. Brown adipose tissue is widely used for
obesity and type II diabetes-related research (23-25). BMP8b
induces thermogenesis in brown adipose tissue and pro-
duces more heat, instead of producing ATP in the body
(7). Hence, the increased weight in the high-fat diet group
can be attributed to the reduced Bmp8b in white adipose
tissue, which is caused by the high-fat diet, the present
study also suggested that metformin or Nigella sativa ex-
tract could restore the activity of Bmp8b. It’s proved that
several processes contribute to BMP7 control, which may
have a positive impact on obesity through influencing the
appetite and mTOR pathway. Thus, targeting this signal-
ing pathway can be considered as an effective approach
in managing obesity (26). In the present study, BMP7 lev-
els didn’t change significantly, thus it can be argued that
weight changes are not correlated with BMP7 levels.
5.1. Conclusions
This study demonstrated that hydro-alcoholic extract
of Nigella sativa not only reduced the weight, but also
showed a protective and therapeutic effect in reducing ox-
idative stress caused by the high-fat diet. According to
the findings of the present study, Nigella sativa could re-
duce the side effects of the high-fat diet. Besides, it was
showed that Nigella sativa is more effective in preventing
obesity than obesity treatment. Nigella sativa extract is
associated with increased expression of the BMP8b gene
in white adipose tissue. BMP8b can increase the conver-
sion of white adipose tissue into brown, so it can be ar-
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gued that white adipose tissue stimulates the thermogen-
esis process, which leads to weight loss.
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